Soluble SORLA Enhances Neurite Outgrowth and Regeneration through Activation of the EGF Receptor/ERK Signaling Axis

SORLA is a transmembrane trafficking protein associated with Alzheimer's disease risk. Although SORLA is abundantly expressed in neurons, physiological roles for SORLA remain unclear. Here, we show that cultured transgenic neurons overexpressing SORLA feature longer neurites, and accelerated neurite regeneration with wounding. Enhanced release of a soluble form of SORLA (sSORLA) is observed in transgenic mouse neurons overexpressing human SORLA, while purified sSORLA promotes neurite extension and regeneration. Phosphoproteomic analyses demonstrate enrichment of phosphoproteins related to the epidermal growth factor (EGFR)/ERK pathway in SORLA transgenic mouse hippocampus from both genders. sSORLA coprecipitates with EGFR in vitro, and sSORLA treatment increases EGFR Y1173 phosphorylation, which is involved in ERK activation in cultured neurons. Furthermore, sSORLA triggers ERK activation, whereas pharmacological EGFR or ERK inhibition reverses sSORLA-dependent enhancement of neurite outgrowth. In search for downstream ERK effectors activated by sSORLA, we identified upregulation of Fos expression in hippocampus from male mice overexpressing SORLA by RNAseq analysis. We also found that Fos is upregulated and translocates to the nucleus in an ERK-dependent manner in neurons treated with sSORLA. Together, these results demonstrate that sSORLA is an EGFR-interacting protein that activates EGFR/ERK/Fos signaling to enhance neurite outgrowth and regeneration. SIGNIFICANCE STATEMENT SORLA is a transmembrane trafficking protein previously known to reduce the levels of amyloid-β, which is critical in the pathogenesis of Alzheimer's disease. In addition, SORLA mutations are a risk factor for Alzheimer's disease. Interestingly, the SORLA ectodomain is cleaved into a soluble form, sSORLA, which has been shown to regulate cytoskeletal signaling pathways and cell motility in cells outside the nervous system. We show here that sSORLA binds and activates the EGF receptor to induce downstream signaling through the ERK serine/threonine kinase and the Fos transcription factor, thereby enhancing neurite outgrowth. These findings reveal a novel role for sSORLA in promoting neurite regeneration through the EGF receptor/ERK/Fos pathway, thereby demonstrating a potential neuroprotective mechanism involving SORLA.

[1]  P. Taimen,et al.  SORLA regulates endosomal trafficking and oncogenic fitness of HER2 , 2019, Nature Communications.

[2]  Jianwei Hou,et al.  Advances in developing novel therapeutic strategies for Alzheimer’s disease , 2018, Molecular Neurodegeneration.

[3]  Eunhee Kim,et al.  Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model , 2018, Science.

[4]  D. Goldstein,et al.  Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer's disease , 2018, Annals of clinical and translational neurology.

[5]  D. Goldstein,et al.  Whole Exome Sequencing in 20,197 Persons for Rare Variants in Alzheimer Disease , 2018, bioRxiv.

[6]  E. Masliah,et al.  SORLA attenuates EphA4 signaling and amyloid β–induced neurodegeneration , 2017, The Journal of experimental medicine.

[7]  Huaxi Xu,et al.  SNX27 and SORLA Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein , 2016, The Journal of Neuroscience.

[8]  M. N. Poy,et al.  SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity. , 2016, The Journal of clinical investigation.

[9]  Hiroyuki Ebinuma,et al.  Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans , 2015, Nature Communications.

[10]  M. Poo,et al.  Autocrine Action of BDNF on Dendrite Development of Adult-Born Hippocampal Neurons , 2015, The Journal of Neuroscience.

[11]  Steven D. Edland,et al.  Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. , 2015, Cell stem cell.

[12]  Xuhui Huang,et al.  Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer’s disease , 2014, Proceedings of the National Academy of Sciences.

[13]  V. Perry,et al.  Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration , 2014, Brain : a journal of neurology.

[14]  D. Holtzman,et al.  Lysosomal Sorting of Amyloid-β by the SORLA Receptor Is Impaired by a Familial Alzheimer’s Disease Mutation , 2014, Science Translational Medicine.

[15]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[16]  T. Willnow,et al.  SORLA-Mediated Trafficking of TrkB Enhances the Response of Neurons to BDNF , 2013, PloS one.

[17]  J. Haines,et al.  SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians , 2013, PloS one.

[18]  K. Fouad,et al.  BDNF: The career of a multifaceted neurotrophin in spinal cord injury , 2012, Experimental Neurology.

[19]  E. Perry,et al.  Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology , 2012, Neurobiology of Disease.

[20]  K. Fouad,et al.  Motor Axonal Regeneration after Partial and Complete Spinal Cord Transection , 2012, The Journal of Neuroscience.

[21]  Linyi Chen,et al.  Interplay between Cell Migration and Neurite Outgrowth Determines SH2B1β-Enhanced Neurite Regeneration of Differentiated PC12 Cells , 2012, PloS one.

[22]  Andrew D Sharrocks,et al.  Immediate-early gene activation by the MAPK pathways: what do and don't we know? , 2012, Biochemical Society transactions.

[23]  J. Nyengaard,et al.  Retromer Binds the FANSHY Sorting Motif in SorLA to Regulate Amyloid Precursor Protein Sorting and Processing , 2012, The Journal of Neuroscience.

[24]  Angelyn R. Lao,et al.  Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease , 2012, The EMBO journal.

[25]  F. Gage,et al.  Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats , 2012, The European journal of neuroscience.

[26]  Jing Wang,et al.  The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats , 2012, Journal of Neural Transmission.

[27]  F. Gage,et al.  Adult hippocampal neurogenesis and its role in Alzheimer's disease , 2011, Molecular Neurodegeneration.

[28]  M. Poo,et al.  Self-amplifying autocrine actions of BDNF in axon development , 2011, Proceedings of the National Academy of Sciences.

[29]  P. Frankland,et al.  Stimulation of Entorhinal Cortex Promotes Adult Neurogenesis and Facilitates Spatial Memory , 2011, The Journal of Neuroscience.

[30]  G. Ding,et al.  Essential role of ERK activation in neurite outgrowth induced by α-lipoic acid. , 2011, Biochimica et biophysica acta.

[31]  P. Topilko,et al.  Secreted Amyloid Precursor Protein β and Secreted Amyloid Precursor Protein α Induce Axon Outgrowth In Vitro through Egr1 Signaling Pathway , 2011, PloS one.

[32]  A. Fenton,et al.  Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation , 2011, Nature.

[33]  R. Treisman,et al.  The Essential Function for Serum Response Factor in T-Cell Development Reflects Its Specific Coupling to Extracellular Signal-Regulated Kinase Signaling , 2010, Molecular and Cellular Biology.

[34]  E. Masliah,et al.  Increased BMP6 Levels in the Brains of Alzheimer's Disease Patients and APP Transgenic Mice Are Accompanied by Impaired Neurogenesis , 2010, The Journal of Neuroscience.

[35]  S. Paul,et al.  Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression , 2009, The Journal of Neuroscience.

[36]  M. Moran,et al.  Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041* , 2009, Molecular & Cellular Proteomics.

[37]  D. Galasko,et al.  Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. , 2009, Archives of neurology.

[38]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[39]  Phillip Hundeshagen,et al.  Activity requires soluble amyloid precursor protein α to promote neurite outgrowth in neural stem cell‐derived neurons via activation of the MAPK pathway , 2008, The European journal of neuroscience.

[40]  W. Schneider,et al.  Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. , 2008, The Journal of clinical investigation.

[41]  D. Selkoe,et al.  Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1 , 2008, Neural Development.

[42]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[43]  K. Murai,et al.  The EphA4 Receptor Regulates Neuronal Morphology through SPAR-Mediated Inactivation of Rap GTPases , 2007, The Journal of Neuroscience.

[44]  A. Di Polo,et al.  Brain-Derived Neurotrophic Factor Gene Transfer With Adeno-Associated Viral and Lentiviral Vectors Prevents Rubrospinal Neuronal Atrophy and Stimulates Regeneration-Associated Gene Expression After Acute Cervical Spinal Cord Injury , 2007, Spine.

[45]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[46]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[47]  W. Schneider,et al.  Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells. , 2006, Biochemical and biophysical research communications.

[48]  J. Gliemann,et al.  Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members. , 2006, The Biochemical journal.

[49]  Vanessa Schmidt,et al.  Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11. , 2006, Biochemistry.

[50]  B. Hyman,et al.  Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and β-Secretase β-Site APP-Cleaving Enzyme , 2006, The Journal of Neuroscience.

[51]  C. Gravel,et al.  BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.

[52]  B. Hyman,et al.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Cotman,et al.  A microfluidic culture platform for CNS axonal injury, regeneration and transport , 2005, Nature Methods.

[54]  J. Wyss,et al.  Neuregulin-1β induces neurite extension and arborization in cultured hippocampal neurons , 2004, Molecular and Cellular Neuroscience.

[55]  A. Levey,et al.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease. , 2004, Archives of neurology.

[56]  Hannah J. Scott,et al.  SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation* , 2004, Journal of Biological Chemistry.

[57]  W. Schneider,et al.  LR11, an LDL Receptor Gene Family Member, Is a Novel Regulator of Smooth Muscle Cell Migration , 2004, Circulation research.

[58]  M. M. Portal,et al.  c-Fos Activated Phospholipid Synthesis Is Required for Neurite Elongation in Differentiating PC12 Cells , 2004 .

[59]  P. Dijkhuizen,et al.  Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury , 2004, Neurobiology of Disease.

[60]  S. Carroll,et al.  Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons. , 2004, Molecular and cellular neurosciences.

[61]  Lin Xie,et al.  Increased hippocampal neurogenesis in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Tuszynski,et al.  Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration , 2003, Experimental Neurology.

[63]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[64]  H. Schaller,et al.  Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator. , 2000, Journal of cell science.

[65]  H. Schaller,et al.  A head-activator binding protein is present in hydra in a soluble and a membrane-anchored form. , 1999, Development.

[66]  J. Bixby,et al.  Distinct Neurite Outgrowth Signaling Pathways Converge on ERK Activation , 1999, Molecular and Cellular Neuroscience.

[67]  H. Schaller,et al.  Unique expression pattern of a novel mosaic receptor in the developing cerebral cortex , 1998, Mechanisms of Development.

[68]  C. Akar,et al.  Amyloid precursor protein potentiates the neurotrophic activity of NGF. , 1997, Brain research. Molecular brain research.

[69]  S. Wiegand,et al.  BDNF and NT-4/5 Prevent Atrophy of Rat Rubrospinal Neurons after Cervical Axotomy, Stimulate GAP-43 and Tα1-Tubulin mRNA Expression, and Promote Axonal Regeneration , 1997, The Journal of Neuroscience.

[70]  H. Dai,et al.  Neurotrophic Factors Increase Axonal Growth after Spinal Cord Injury and Transplantation in the Adult Rat , 1997, Experimental Neurology.

[71]  E. Feldman,et al.  Insulin-like Growth Factor-I-mediated Neurite Outgrowth in Vitro Requires Mitogen-activated Protein Kinase Activation* , 1997, The Journal of Biological Chemistry.

[72]  J. Houlé,et al.  Treatment of the Chronically Injured Spinal Cord with Neurotrophic Factors Can Promote Axonal Regeneration from Supraspinal Neurons , 1997, Experimental Neurology.

[73]  N. Tommerup,et al.  Molecular Characterization of a Novel Human Hybrid-type Receptor That Binds the α2-Macroglobulin Receptor-associated Protein* , 1996, The Journal of Biological Chemistry.

[74]  R. Janknecht Regulation of the c-fos promoter. , 1995, Immunobiology.

[75]  J. Schlessinger,et al.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor , 1994, Molecular and cellular biology.

[76]  Y. Kido,et al.  Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells. , 1994, The Journal of biological chemistry.

[77]  A. Nordheim,et al.  Activation of ternary complex factor Elk‐1 by MAP kinases. , 1993, The EMBO journal.

[78]  C. Masters,et al.  The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.

[79]  A. Leon,et al.  Nerve Growth Factor Transcriptional Control of C-fos Promoter Transfected in Cultured Spinal Sensory Neurons Materials and Methods Preparation of Neuronal Cultures , 2022 .

[80]  S. Shimohama,et al.  Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture. , 1991, Biochemical and biophysical research communications.

[81]  Michael Alford,et al.  Patterns of aberrant sprouting in alzheimer's disease , 1991, Neuron.

[82]  Tsonwin Hai,et al.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.